Hoepken, B.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Business intelligence and big data in hospitality and tourism: a systematic literature review

Mariani, Marcello, Baggio, Rodolfo, Fuchs, Matthias, Höepken, Wolfram

Journal:

International Journal of Contemporary Hospitality Management

Year:

2018

Language:

english

File:

PDF, 445 KB

english, 2018

2

War, Memory, and Education in a Fragmented Society: the Case of Yugoslavia

Journal:

East European Politics & Societies

Year:

1998

Language:

english

File:

PDF, 3.73 MB

english, 1998

3

e-Tourism beyond COVID-19: a call for transformative research

Gretzel, Ulrike, Fuchs, Matthias, Baggio, Rodolfo, Hoepken, Wolfram, Law, Rob, Neidhardt, Julia, Pesonen, Juho, Zanker, Markus, Xiang, Zheng

Journal:

Information Technology & Tourism

Year:

2020

File:

PDF, 775 KB

2020

4

Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial

Walsh, J. A., Gottlieb, A. B., Hoepken, B., Nurminen, T., Mease, P. J.

Journal:

Clinical Rheumatology

Year:

2018

Language:

english

File:

PDF, 1.10 MB

english, 2018

5

Correction to: Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial

Walsh, J. A., Gottlieb, A. B., Hoepken, B., Nurminen, T., Mease, P. J.

Journal:

Clinical Rheumatology

Year:

2018

Language:

english

File:

PDF, 283 KB

english, 2018

6

Glutathione peroxidase 1 and glutathione are required to protect mouse astrocytes from iron-mediated hydrogen peroxide toxicity

Jeff R. Liddell, Hans H. Hoepken, Peter J. Crack, Stephen R. Robinson, Ralf Dringen

Journal:

Journal of Neuroscience Research

Year:

2006

Language:

english

File:

PDF, 278 KB

english, 2006

7

Colorimetric ferrozine-based assay for the quantitation of iron in cultured cells

Jan Riemer, Hans Hermann Hoepken, Hania Czerwinska, Stephen R Robinson, Ralf Dringen

Journal:

Analytical Biochemistry

Year:

2004

Language:

english

File:

PDF, 362 KB

english, 2004

8

Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate

Hans H. Hoepken, Till Korten, Stephen R. Robinson, Ralf Dringen

Journal:

Journal of Neurochemistry

Year:

2004

Language:

english

File:

PDF, 235 KB

english, 2004

9

Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6

Hans-Hermann Hoepken, Suzana Gispert, Blas Morales, Oliver Wingerter, Domenico Del Turco, Alexander Mülsch, Robert L. Nussbaum, Klaus Müller, Stefan Dröse, Ulrich Brandt, Thomas Deller, Brunhilde Wirt

Journal:

Neurobiology of Disease

Year:

2007

Language:

english

File:

PDF, 1.15 MB

english, 2007

10

Parkinson patient fibroblasts show increased alpha-synuclein expression

Hans-Hermann Hoepken, Suzana Gispert, Mekhman Azizov, Michael Klinkenberg, Filomena Ricciardi, Alexander Kurz, Blas Morales-Gordo, Michael Bonin, Olaf Riess, Thomas Gasser, Donat Kögel, Helmuth Steinm

Journal:

Experimental Neurology

Year:

2008

Language:

english

File:

PDF, 370 KB

english, 2008

11

277: The Role of Indoleamine 2,3-Dioxygenase (IDO) on Maintenance of Immunological Tolerance to Cardiac Allografts

I. Schmitt-Knosalla, S. Broesel, D. Lange, A. Andersson, U. Hoepken, M. Dandel, H.B. Lehmkuhl, H.-D. Volk, M. Bader, R. Hetzer, C. Knosalla

Journal:

The Journal of Heart and Lung Transplantation

Year:

2009

Language:

english

File:

PDF, 164 KB

english, 2009

12

Loss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by Parkin

Exner, N., Treske, B., Paquet, D., Holmstrom, K., Schiesling, C., Gispert, S., Carballo-Carbajal, I., Berg, D., Hoepken, H.-H., Gasser, T., Kruger, R., Winklhofer, K. F., Vogel, F., Reichert, A. S., A

Journal:

Journal of Neuroscience

Year:

2007

Language:

english

File:

PDF, 433 KB

english, 2007

13

Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)

Mease, P. J., Fleischmann, R., Deodhar, A. A., Wollenhaupt, J., Khraishi, M., Kielar, D., Woltering, F., Stach, C., Hoepken, B., Arledge, T., van der Heijde, D.

Journal:

Annals of the Rheumatic Diseases

Year:

2014

Language:

english

File:

PDF, 1.83 MB

english, 2014

14

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

Landewe, R., Braun, J., Deodhar, A., Dougados, M., Maksymowych, W. P., Mease, P. J., Reveille, J. D., Rudwaleit, M., van der Heijde, D., Stach, C., Hoepken, B., Fichtner, A., Coteur, G., de Longuevill

Journal:

Annals of the Rheumatic Diseases

Year:

2014

Language:

english

File:

PDF, 2.03 MB

english, 2014

15

[IEEE 21st Design Automation Conference Proceedings - Albuquerque, NM, USA (1984.06.25-1984.06.27)] 21st Design Automation Conference Proceedings - A Technology Independent Block Extraction Algorithm

Luellau, F., Hoepken, T., Barke, E.

Year:

1984

Language:

english

File:

PDF, 464 KB

english, 1984

16

LB0001 Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24 week results of a phase 3 double blind randomized placebo-controlled study (rapid-PSA)

Mease, P. J., Fleischmann, R., Deodhar, A., Wollenhaupt, J., Kielar, D., Woltering, F., Stach, C., Hoepken, B., Arledge, T., van der Heijde, D.

Journal:

Annals of the Rheumatic Diseases

Year:

2012

Language:

english

File:

PDF, 180 KB

english, 2012

17

[IEEE 2009 12th International IEEE Conference on Intelligent Transportation Systems (ITSC) - St. Louis (2009.10.4-2009.10.7)] 2009 12th International IEEE Conference on Intelligent Transportation Systems - A multi sensor system to evaluate driving behavior in curves

Year:

2009

Language:

english

File:

PDF, 1.10 MB

english, 2009

18

SAT0298 Effect of Certolizumab Pegol on Signs and Symptoms in Patients with Psoriatic Arthritis from the Rapid-PSA Study: Impact of Baseline Skin Involvement and Prior Anti-TNF Therapy

Mease, P. J., Fleischmann, R., Wollenhaupt, J., Deodar, A., Kielar, D., Woltering, F., Stach, C., Hoepken, B., Arledge, T., van der Heijde, D.

Journal:

Annals of the Rheumatic Diseases

Year:

2013

Language:

english

File:

PDF, 351 KB

english, 2013

19

Effect of Certolizumab Pegol Over Ninety-Six Weeks in Patients With Axial Spondyloarthritis: Results from a Phase III Randomized Trial

Sieper, J., Landewé, R., Rudwaleit, M., van der Heijde, D., Dougados, M., Mease, P. J., Braun, J., Deodhar, A., Kivitz, A., Walsh, J., Hoepken, B., Nurminen, T., Maksymowych, W. P.

Journal:

Arthritis & Rheumatology

Year:

2015

Language:

english

File:

PDF, 2.13 MB

english, 2015

20

Development of a standardized trauma-related lung injury model

Pfeifer, Roman, Andruszkow, Julia H.K., Busch, Daniel, Hoepken, Merle, Barkatali, Bilal M., Horst, Klemens, Pape, Hans-Christoph, Hildebrand, Frank

Journal:

Journal of Surgical Research

Year:

2015

Language:

english

File:

PDF, 1.44 MB

english, 2015

21

Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol

van der Heijde, D., Fleischmann, R., Wollenhaupt, J., Deodhar, A., Kielar, D., Woltering, F., Stach, C., Hoepken, B., Arledge, T., Mease, P. J.

Journal:

Annals of the Rheumatic Diseases

Year:

2014

Language:

english

File:

PDF, 849 KB

english, 2014

22

OP0171 Achievement of Remission of Inflammation in the Spine and Sacroiliac Joints Measured by Magnetic Resonance Imaging (MRI) in Patients with Axial Spondyloarthritis, and Associations Between MRI and Clinical Remission, Over 96 Weeks of Treatment with Certolizumab Pegol:

Braun, J., Maksymowych, W.P., Landewé, R., Baraliakos, X., Hermann, K.-G., Machado, P., Hoepken, B., Stach, C., Davies, O., Nurminen, T., van der Heijde, D.

Journal:

Annals of the Rheumatic Diseases

Year:

2015

Language:

english

File:

PDF, 236 KB

english, 2015

23

Effect of certolizumab pegol over 96 weeks in patients with psoriatic arthritis with and without prior antitumour necrosis factor exposure

Mease, P, Deodhar, A, Fleischmann, R, Wollenhaupt, J, Gladman, D, Leszczyński, P, Vitek, P, Turkiewicz, A, Khraishi, M, FitzGerald, O, Landewé, R, de Longueville, M, Hoepken, B, Peterson, L, van der H

Journal:

Year:

2015

Language:

english

File:

PDF, 4.16 MB

english, 2015

24

Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis

Rudwaleit, M., Rosenbaum, J. T., Landewé, R., Marzo-Ortega, H., Sieper, J., van der Heijde, D., Davies, O., Bartz, H., Hoepken, B., Nurminen, T., Deodhar, A.

Journal:

Arthritis Care & Research

Year:

2016

Language:

english

File:

PDF, 124 KB

english, 2016

25

Splenic marginal zone granulocytes acquire an accentuated neutrophil B cell-helper phenotype in chronic lymphocytic leukemia

Ga tjen, M., Brand, F., Grau, M., Gerlach, K., Kettritz, R., Westermann, J., Anagnostopoulos, I., Lenz, P., Lenz, G., Hoepken, U. E., Rehm, A.

Journal:

Cancer Research

Year:

2016

Language:

english

File:

PDF, 16.61 MB

english, 2016

26

OP0077 Long-Term Safety and Efficacy of Certolizumab Pegol in Patients with Psoriatic Arthritis with and without Prior Anti-Tumor Necrosis Factor Exposure: 96-Week Outcomes from the Rapid-Psa Trial

Mease, P.J., Fleischmann, R., Wollenhaupt, J., Deodhar, A., Gladman, D., Hoepken, B., Peterson, L., van der Heijde, D.

Journal:

Annals of the Rheumatic Diseases

Year:

2014

Language:

english

File:

PDF, 134 KB

english, 2014

27

FRI0471 Certolizumab Pegol for The Treatment of Psoriatic Arthritis: 4-Year Outcomes from The Rapid-Psa Trial

Mease, P.J., Fleischmann, R., Wollenhaupt, J., Deodhar, A., Gladman, D., Hoepken, B., Peterson, L., van der Heijde, D.

Journal:

Annals of the Rheumatic Diseases

Year:

2016

Language:

english

File:

PDF, 258 KB

english, 2016

28

FRI0472 Improvements in Joint Outcomes of Psoriatic Arthritis over 4 Years of Treatment with Certolizumab Pegol in Patients with and without Prior Anti-TNF Exposure

Mease, P.J., Fleischmann, R., Wollenhaupt, J., Deodhar, A., Gladman, D., Hoepken, B., Peterson, L., van der Heijde, D.

Journal:

Annals of the Rheumatic Diseases

Year:

2016

Language:

english

File:

PDF, 113 KB

english, 2016

29

THU0417 Improvements in Extra-Articular Manifestations of Psoriatic Arthritis Over 96 Weeks of Certolizumab Pegol Treatment

FitzGerald, O., Fleischmann, R., Hoepken, B., Peterson, L., Gladman, D.

Journal:

Annals of the Rheumatic Diseases

Year:

2015

Language:

english

File:

PDF, 131 KB

english, 2015

30

Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis

Braun, Jürgen, Baraliakos, Xenofon, Hermann, Kay-Geert, Landewé, Robert, Machado, Pedro M, Maksymowych, Walter P, Davies, Owen, Hoepken, Bengt, Nurminen, Tommi, Stach, Christian, van der Heijde, Désir

Journal:

Year:

2017

Language:

english

File:

PDF, 1020 KB

english, 2017

31

SAT0375 Certolizumab Pegol for The Treatment of Axial Spondyloarthritis: 4-Year Outcomes from The Rapid-AXSPA Trial

van der Heijde, D., Dougados, M., Landewé, R., Sieper, J., Maksymowych, W.P., Rudwaleit, M., van den Bosch, F., Braun, J., Mease, P.J., Davies, O., Hoepken, B., Peterson, L., Deodhar, A.

Journal:

Annals of the Rheumatic Diseases

Year:

2016

Language:

english

File:

PDF, 132 KB

english, 2016

32

FRI0419 Effect of certolizumab pegol on inflammation of spine and sacroiliac joints in patients with axial spondyloarthritis: 12-week magnetic resonance imaging results of rapid-axspa study

van der Heijde, D., Maksymowych, W. P., Landewé, R., Stach, C., Hoepken, B., Fichtner, A., Kielar, D., Braun, J.

Journal:

Annals of the Rheumatic Diseases

Year:

2013

Language:

english

File:

PDF, 398 KB

english, 2013

33

SAT0351 Long-Term Safety and Efficacy of Certolizumab Pegol in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 96-Week Outcomes of the Rapid-Axspa Trial

Sieper, J., Rudwaleit, M., van der Heijde, D., Maksymowych, W., Dougados, M., Mease, P.J., Braun, J., Deodhar, A., Hoepken, B., Nurminen, T., Landewé, R.

Journal:

Annals of the Rheumatic Diseases

Year:

2014

Language:

english

File:

PDF, 239 KB

english, 2014

34

THU0427 Sustained Improvements in Skin Outcomes Following Certolizumab Pegol Treatment of Psoriatic Arthritis Patients with Prior Anti-TNF Exposure or Severe Skin Involvement at Baseline

Khraishi, M., Hoepken, B., Davies, O., Arledge, T., Peterson, L., Mease, P.J.

Journal:

Annals of the Rheumatic Diseases

Year:

2015

Language:

english

File:

PDF, 182 KB

english, 2015

35

[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Oral Presentations - OP0023 Four-year imaging outcomes in axial spondyloarthritis patients treated with certolizumab pegol, including patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis

Heijde, D van der, Baraliakos, X, Hermann, KG, Landewé, R, Machado, PM, Maksymowych, W, Davies, O, Peyrecave, N de, Hoepken, B, Bauer, L, Nurminen, T, Braun, J

Language:

english

File:

PDF, 459 KB

english

36

[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Abstracts Accepted for Publication - AB0747 The effect of certolizumab pegol on radiographic progression over 4 years of treatment in patients with psoriatic arthritis

Heijde, D van der, Fleischmann, R, Wollenhaupt, J, Deodhar, A, Bauer, L, Hoepken, B, Peterson, L, Mease, PJ

Language:

english

File:

PDF, 190 KB

english

37

Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial

van der Heijde, Désirée, Baraliakos, Xenofon, Hermann, Kay-Geert A, Landewé, Robert B M, Machado, Pedro M, Maksymowych, Walter P, Davies, Owen R, de Peyrecave, Natasha, Hoepken, Bengt, Bauer, Lars, Nu

Journal:

Annals of the Rheumatic Diseases

Year:

2018

Language:

english

File:

PDF, 1.97 MB

english, 2018

38

4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis

van der Heijde, Désirée, Deodhar, Atul, FitzGerald, Oliver, Fleischmann, Roy, Gladman, Dafna, Gottlieb, Alice B, Hoepken, Bengt, Bauer, Lars, Irvin-Sellers, Oscar, Khraishi, Majed, Peterson, Luke, Tur

Journal:

Year:

2018

Language:

english

File:

PDF, 1.30 MB

english, 2018

39

SAT0281 Impact of Imputation Methodology on Radiographic Progression Outcomes in the Rapid-Psa Study Of Certolizumab Pegol In Patients With Psoriatic Arthritis

van der Heijde, D., Fleischmann, R., Wollenhaupt, J., Deodhar, A., Kielar, D., Woltering, F., Stach, C., Hoepken, B., Arledge, T., Mease, P. J.

Journal:

Annals of the Rheumatic Diseases

Year:

2013

Language:

english

File:

PDF, 352 KB

english, 2013

40

OP0106 Effect of Certolizumab Pegol on Signs and Symptoms of Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 24-Week Results of Rapid-Axspa Study

Landewé, R., Rudwaleit, M., van der Heijde, D., Dougados, M., Maksymowych, W. P., Braun, J., Deodhar, A., Stach, C., Hoepken, B., Coteur, G., Kielar, D., Fichtner, A., Arledge, T., Sieper, J.

Journal:

Annals of the Rheumatic Diseases

Year:

2013

Language:

english

File:

PDF, 412 KB

english, 2013

41

THU0201 Factors Associated with Structural Damage in the Spine, as Measured by X-ray, in Patients with Axial Spondyloarthritis Treated with Certolizumab Pegol Over 96 Weeks

van der Heijde, D., Maksymowych, W.P., Landewé, R., Stach, C., Hoepken, B., Davies, O., Nurminen, T., Braun, J.

Journal:

Annals of the Rheumatic Diseases

Year:

2015

Language:

english

File:

PDF, 140 KB

english, 2015

42

[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Poster Presentations - FRI0508 The effect of certolizumab pegol on extra-articular manifestations of psoriatic arthritis over 4 years of treatment in patients with and without prior anti-tnf exposure

FitzGerald, O, Fleischmann, R, Kavanaugh, A, Hoepken, B, Peterson, L, Gladman, D

Language:

english

File:

PDF, 269 KB

english

43

Progression of pathology in PINK1-deficient mouse brain from splicing via ubiquitination, ER stress, and mitophagy changes to neuroinflammation

Torres-Odio, Sylvia, Key, Jana, Hoepken, Hans-Hermann, Canet-Pons, Júlia, Valek, Lucie, Roller, Bastian, Walter, Michael, Morales-Gordo, Blas, Meierhofer, David, Harter, Patrick N., Mittelbronn, Miche

Journal:

Journal of Neuroinflammation

Year:

2017

Language:

english

File:

PDF, 10.35 MB

english, 2017

44

Parkinson Phenotype in Aged PINK1-Deficient Mice Is Accompanied by Progressive Mitochondrial Dysfunction in Absence of Neurodegeneration

Gispert, Suzana, Ricciardi, Filomena, Kurz, Alexander, Azizov, Mekhman, Hoepken, Hans-Hermann, Becker, Dorothea, Voos, Wolfgang, Leuner, Kristina, Müller, Walter E., Kudin, Alexei P., Kunz, Wolfram S.

Journal:

Year:

2009

Language:

english

File:

PDF, 2.31 MB

english, 2009

45

Effects of Ustekinumab versus Tumor Necrosis Factor Inhibition on Enthesitis- Results from the Enthesial Clearance in Psoriatic Arthritis (ECLIPSA) study

Araujo, Elizabeth G., Englbrecht, Matthias, Hoepken, Sabrina, Finzel, Stephanie, Kampylafka, Eleni, Kleyer, Arnd, Bayat, Sarah, Schoenau, Verena, Hueber, Axel, Rech, Juergen, Schett, Georg

Journal:

Seminars in Arthritis and Rheumatism

Year:

2018

Language:

english

File:

PDF, 751 KB

english, 2018

46

162 Efficacyand safety of certolizumab pegol over four years in psoriatic arthritis patientswith and without concomitant use of DMARDs

Cooper, Robert G, Walsh, Jessica, Gottlieb, Alice B, Hoepken, Bengt, Nurminen, Tommi, Mease, Philip J

Journal:

Year:

2018

Language:

english

File:

PDF, 32 KB

english, 2018

47

213. Effect of Certolizumab Pegol on Inflammation of Spine and Sacroiliac Joints in Patients with Axial Spondyloarthritis: 12-Week Magnetic Resonance Imaging Results of Rapid-Axspa Study

van der Heijde, Désirée, Maksymowych, Walter P., Landewé, Robert, Stach, Christian, Hoepken, Bengt, Fichtner, Andreas, Kielar, Danuta, Braun, Juergen

Journal:

Year:

2014

Language:

english

File:

PDF, 63 KB

english, 2014

48

Scanning probe microscopy and potentiometry using a junction field effect transistor based sensor

Graf, Paul, Flebbe, Meike, Hoepken, Stephanie, Utzat, Detlef, Nienhaus, Hermann, Möller, Rolf

Journal:

Applied Physics Letters

Year:

2018

Language:

english

File:

PDF, 1.57 MB

english, 2018

49

A 52-Week Randomized Placebo-Controlled Trial of Certolizumab Pegol in Non-Radiographic Axial Spondyloarthritis

Deodhar, Atul, Gensler, Lianne S., Kay, Jonathan, Maksymowych, Walter P., Haroon, Nigil, Landewé, Robert, Rudwaleit, Martin, Hall, Stephen, Bauer, Lars, Hoepken, Bengt, de Peyrecave, Natasha, Kilgalle

Journal:

Arthritis & Rheumatology

Year:

2019

Language:

english

File:

PDF, 847 KB

english, 2019

50

246 Safety and effectiveness of certolizumab pegol in axial spodyloarthritis in a real-world setting: a UK sub-analysis from a European non-interventional study

Marzo-Ortega, Helena, Sengupta, Raj, Goodson, Nicola, Ho, Pauline, Mackay, Kirsten, Hoepken, Bengt, VanLunen, Brenda, Baraliakos, Xenofon

Journal:

Year:

2019

Language:

english

File:

PDF, 70 KB

english, 2019